RO

Roche Holding AG (ROG)

HealthcareDrug Manufacturers - General
324.90CHF
+4.13%
Magic Rank
#8
Earnings Yield
7.1%
Return on Capital
179.6%
Cap. Boursière
256.4B

Performance vs S&P 500 (5 ans)

ROG.SW
S&P 500

À propos Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Analyse Magic Formula

Valeur d'Entreprise272.9B
Marché / Univers
ch
Suisse

"Une entreprise avec un ROC élevé et un EY élevé a statistiquement plus de chances de surperformer le marché."

Indicateurs Clés

P/E Ratio20.11
Rendement dividende3.1%
Dette / Fonds propres0.49
Marge Brute30.0%